Rafa Laboratories Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Rafa Laboratories Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10894
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rafa Laboratories Ltd (Rafa) is a pharmaceutical company that manufactures and distributes medicines and consumer health products. The company offers prescription, over-the-counter medicines, proprietary formulations, generic formulations and consumer health products. It offers scale-up and commercial manufacturing capabilities, logistics and storage services, dedicated tech transfer, quality assurance and quality control, and packaging, labeling and distribution. Rafa offers medicines for newborns to aging adults. The company offers medicines in areas of pain, palliative care, gastrointestinal, respiratory, dermatology, psychiatry and consumer health. It operates through its manufacturing facilities and distribution network across Israel. Rafa is headquartered in Jerusalem, Israel.

Rafa Laboratories Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
AXIM Biotech Enters into Distribution Agreement with Rafa Labs 10
Licensing Agreements 11
Rafa Labs Enters into Licensing Agreement with Aeterna Zentaris 11
OSE Pharma Enters into Licensing Agreement with RAFA Labs 12
Rafa Laboratories Ltd – Key Competitors 13
Rafa Laboratories Ltd – Key Employees 14
Rafa Laboratories Ltd – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rafa Laboratories Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AXIM Biotech Enters into Distribution Agreement with Rafa Labs 10
Rafa Labs Enters into Licensing Agreement with Aeterna Zentaris 11
OSE Pharma Enters into Licensing Agreement with RAFA Labs 12
Rafa Laboratories Ltd, Key Competitors 13
Rafa Laboratories Ltd, Key Employees 14
Rafa Laboratories Ltd, Other Locations 15

List of Figures
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Rafa Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Rafa Laboratories Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Chiba Kogyo Bank, Ltd.:企業の戦略・SWOT・財務分析
    SummaryThe Chiba Kogyo Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. …
  • Nippon Valqua Industries, Ltd. (7995):企業財務及び戦略的SWOT分析
    Summary Nippon Valqua Industries, Ltd. (Valqua) is an industrial equipment company that designs, manufactures, and markets fibre, fluorocarbon resin, high-functional rubber and other materials. The company offers products such as seal, piping, lubricant and moving material; electric and electronical …
  • Athlon Energy Inc. (ATHL):企業概要、財務及び戦略的SWOT分析
    Summary Athlon Energy Inc. (Athlon Energy) is an independent exploration and production company. The company focuses on the acquisition, development and exploitation of liquids-rich natural gas and unconventional oil reserves especially in the Permian Basin. Currently, the company operates in three …
  • Skyworks Solutions, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Skyworks Solutions, Inc. Merger …
  • MicroJet Technology Co., Ltd. (8197):企業概要、財務及び戦略的SWOT分析
    Summary MicroJet Technology Co., Ltd. (MicroJet) is a printing products manufacturing company. The company designs and manufactures Inkjet Printheads, Inkjet Printers and Piezo-electric Devices. It offers inkjet printing products such as Inkjet Print Heads, Inkjet Print Cartridges, Custom Inkjet Eng …
  • SARomics Biostructures AB:製薬・医療:M&Aディール及び事業提携情報
    Summary SARomics Biostructures AB (Saromics) is a contract research organization that offers structural biology and drug discovery outsourcing services platform for biotech and pharmaceutical companies. The organization provides services in protein crystallization, protein crystallography, protein N …
  • Nemaura Pharma Limited(製薬・医療分野):企業M&A動向
    Summary Nemaura Pharma Limited (Nemaura Pharma) is a pharmaceutical drug delivery company. It undertakes the development of transdermal systems with proprietary platform technologies for the non-invasive monitoring of analytes through the skin. The company’s technologies include passive transdermal …
  • KDDI Corporation:企業のM&A・事業提携・投資動向
    KDDI Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's KDDI Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Triumph Group, Inc.:企業のM&A・提携・投資分析
    Triumph Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Triumph Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • EndoGastric Solutions, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' EndoGastric Solutions, Inc. Mer …
  • China State Shipbuilding Corp:企業の戦略・SWOT・財務情報
    China State Shipbuilding Corp - Strategy, SWOT and Corporate Finance Report Summary China State Shipbuilding Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Showa Shell Sekiyu K.K.:企業の戦略・SWOT・財務分析
    SummaryShowa Shell Sekiyu K.K. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • In House Productions Limited (526610):企業の財務及び戦略的SWOT分析
    Summary In House Productions Limited (IHPL), a subsidiary of World Media Group Pte Ltd, is a software company that develops software for television. The company offers products such as television software, content production, documentaries, animation, TV commercials, music videos and feature films. …
  • Nuo Therapeutics Inc:企業のM&A・提携動向(医療機器分野)
    Summary Nuo Therapeutics Inc (Nuo Therapeutics), formerly Cytomedix, Inc., is a biomedical company, which specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural he …
  • Honeywell Advanced Fibers and Composites:企業の戦略・SWOT・財務分析
    SummaryHoneywell Advanced Fibers and Composites - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of …
  • Icon Energy Limited (ICN):企業財務及び戦略的SWOT分析
    Summary Icon Energy Limited (Icon Energy), formerly Icon Oil NL is an oil and gas company that offers exploration, appraisal and development services. The company’s exploration tenements include ATP 855, PRL's 33-49, ATP 594, ATP 626, ATP 794, ATP 549 West, PEP 170, PEP 172, and PEP 173. Its ATP 549 …
  • Qualcomm Incorporated (QCOM):企業のM&A・提携動向(エネルギー分野)
    Summary Qualcomm Incorporated (Qualcomm) is a technology and communication company. The company designs and manufactures digital wireless telecommunications products and services. Qualcomm offers integrated circuits and system software for wireless mobile devices. The major technologies such as code …
  • Sun-Rype Products Ltd.:企業の戦略・SWOT・財務情報
    Sun-Rype Products Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sun-Rype Products Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Meyer Burger Technology AG (MBTN):企業の財務及び戦略的SWOT分析
    Meyer Burger Technology AG (MBTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • CSA Medical, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary CSA Medical, Inc. (CSA Medical) is a medical technology company. The company offers spray cryotherapy medical device solutions to improve patient outcomes; simplify procedures; and reduce the cost of healthcare. Its truFreeze system delivers cold liquid nitrogen spray through a small cathete …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆